FDA pegcetacoplan coverage for business development, investment, and market access teams
Syfovre has received FDA approval as the first-ever treatment for geographic atrophy, marking a significant advancement in managing this debilitating condition.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
